FDA inspection
Ipsen Pharma Biotech: FDA inspection ending Mar 29, 2024
FDA inspection 1298514 · Voluntary Action Indicated (VAI) · Signes
Key facts
| Inspection ID | 1298514 |
|---|---|
| Firm | Ipsen Pharma Biotech |
| FEI number | 3003749112 |
| Address | 402 Parc Dactivite De Signes Che Departemental |
| City | Signes |
| Country | France |
| Fiscal year | 2024 |
| Inspection end date | Mar 29, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data